New dosing study aims to cut blood loss in joint replacements
NCT ID NCT05075200
First seen Jan 05, 2026 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This study tested different doses of tranexamic acid (TXA) to find the best amount to give during hip or knee replacement surgery. TXA helps reduce bleeding and the need for blood transfusions. Researchers measured TXA levels in the blood of 21 adults to build a model for future dosing guidelines, especially for patients with kidney problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHROPLASTY, REPLACEMENT, KNEE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.